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Objective: We describe a prenatal ultrasonography diagnosis of omphalocele and symbrachydactyly in a
fetus and review the literature on prenatal diagnosis of 9p terminal chromosomal deletions.
Case report: A 31-year-old woman (gravida 3, para 1) was referred for genetic counseling because a fetal
omphalocele had been detected. Prenatal ultrasonography at 17þ weeks of gestational age revealed a
singleton female fetus with biometry equivalent to 18 weeks with an omphalocele. In addition, sym-
brachydactyly was also noted in the right arm; the wrist bones as well as the metacarpals were missing.
A chromosomal study was arranged for a congenital anomaly involving omphalocele. We obtained
Giemsa-banded chromosomes from fetal tissue cells, and an abnormal male karyotype with a terminal
deletion of the short arm of chromosome 9 at band 9p13 was noted. After delivery, the fetus showed
omphalocele, symbrachydactyly, trigonocephaly, sex reversal, a long philtrum, low-set ears, telecanthus,
and a frontal prominence.
Conclusion: Prenatal diagnosis of abnormal ultrasound ﬁndings with omphalocele and symbrachydactyly
should include the differential diagnosis of a chromosome 9p deletion.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Deletion 9p syndrome is awell-known chromosomal disorder. It
is characterized by craniofacial dysmorphisms, such as cranioste-
nosis with trigonocephaly, a prominent forehead with a metopic
ridge, midfacial hypoplasia, a ﬂat nasal bridge, anteverted nares,
low-set poorly formed ears, a long philtrum, developmental delay,
mental retardation, seizuresand impaired learningability, abnormal
digits, cardiovascular defects, and gonadal abnormalities as well as
short arms and an umbilical hernia [1e11]. Marked developmental
delay with attention deﬁcit hyperactivity disorder and peripheraland Gynecology, Tri-Service
ihu District, Taipei, Taiwan.
bstetrics & Gynecology. Publishedmyopathy involving intentional tremor and myoclonic jerking are
associated with the 9p13 interstitial deletion [12].
Isolated omphalocele is a rare congenital deformity, occurring in
approximately two to three per 10,000 live births [13]. Omphalo-
celes occur sporadically, and about 56% of the affected patients
show karyotypic anomalies, including trisomies 13, 15, 16, and 18
and Beckwith-Wiedemann syndrome [14e16].
As for right upper limb deformities, symbrachydactyly was ﬁrst
named by Blauth and Gekeler in 1973. This is regarded as a trans-
verse deﬁciency, caused by bony dysplasia, graded by its severity
into four categories [17]. The common clinical features are unilat-
eral and some cases are associated with anomalies in the pectoral
muscle (Poland syndrome) [18]. The prevalence of skeletal
dysplasia is 2.14 per 10,000 deliveries [19]. In our case, all digits
were absent, although some rudimental ﬁngers were observed.
According to the Blauth and Gekeler classiﬁcation, this fetusby Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Prenatal ultrasonography at 17þ weeks of gestational age revealed a
2.02  1.96 cm isolated omphalocele. Fig. 3. Karyotype of the fetus revealed 46,XY,del(9)(p13), and the breakpoint is marked
by the arrow.
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cause has not been established [17].
Here, we present a case of chromosome 9p deletion with the
typical symptoms mentioned above and two other rare symptoms:
omphalocele and symbrachydactyly.
Case report
A 31-year-old woman (gravida 3, para 1) was referred to our
hospital for genetic counseling after an omphalocele was detected
in the fetus. The woman was Taiwanese and not obese. Neither she
nor her husband showed any substance abuse. There was no familyFig. 2. (A) Photograph of a fetus showing metopic prominence, telecanthus, long philtrum, lo
upper extremities and symbrachydactyly are shown.history of congenital malformations. Maternal serum screening
showed that the levels of a-fetoprotein, unconjugated estriol, total
b-human chorionic gonadotropin, and inhibin-A were 0.78, 0.82,
1.27, and 1.63 multiples of median, respectively. Risk evaluation
results were calculated as a probability of 1/335 of having Down
syndrome, 1/5,5900 of having an open neural tube defect, and 1/
32,200 of having trisomy 18. Prenatal ultrasound was arranged at
17 2/7 weeks gestational age and showed a 188-g singleton fetus
with biometry equivalent to 18 weeks of gestation, a normal
amount of amniotic ﬂuid, and a 2.02  1.96 cm isolated omphalo-
cele (Fig. 1). In addition, symbrachydactyly was observed over thew-set ears, omphalocele, midfacial hypoplasia, and omphalocele. (B, C) Shortened right
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pulmar region, and a shortened forearm and upper arm. The
woman underwent medical termination of the pregnancy because
of these fetal malformations, and a chromosomal study was
arranged, including Giemsa-banded karyotypes of the fetus and
parents. The 350-g ostensibly female fetus was delivered at 19 6/7
weeks of gestational age and showed omphalocele, sym-
brachydactyly, trigonocephaly, a long philtrum, low-set ears,
telecanthus, a metopic prominence, and sex reversal (Fig. 2).
Chromosome culture and karyotyping was performed on fetal tis-
sue cells. Nineteenmetaphase spreads were analyzed using Giemsa
banding. The maximum resolution achieved was 400 bands. The
metaphases from the fetus revealed terminal deletion of the short
arm of chromosome 9. The karyotypewas 46,XY,del(9)(p13) (Fig. 3),
conﬁrming a sex reversal phenotype. Parental peripheral blood
chromosomal analyses were normal. Hence, a de novo 9p deletion
was diagnosed.
Discussion
Chromosomal abnormalities, including the 9p deletion syn-
drome, can be detected in early pregnancy by evaluating maternal
serum biochemistry [20e25]. In our case, the serum studies were
normal and the relative risk of Down syndrome 1/335. High-
resolution mapping techniques, such as ﬂuorescence in situ
hybridization and microarray-based comparative genomic hybrid-
ization, might be able to detect the precise region of the deletion
and eliminate other chromosomal anomalies, but such techniques
had not been established for this case.
The current case was associated with a chromosomal 9p ter-
minal deletion with a breakpoint at p13. This 9p terminal deletion
produces haploinsufﬁciencies of the DOCK8, DMRT1, DMRT2, and
DMRT3 genes [21]. Genomic aberrations of DOCK8 are associated
with the failed organization of ﬁlamentous actin of adult and fetal
brains, subsequently resulting in mental retardation [26]. The
DMRT clusters are known as candidate genes for sex determination
and differentiation in mammals, involved in suppressing female
differentiation and maintaining mammalian testis determination
[27,28].
For trigonocephaly, a critical region has been discovered
strongly associated with genomic regions from D9S912 to RP11-
439I6 [29]. The CER1 gene was hypothesized to be one of the crit-
ical genes, but two other studies disproved it [5,30].
In fact, fetuses with 9p deletion syndrome might survive. In
some cases, they have even lived as long as 4 decades. Nevertheless,
developmental delay, including motor and speech disorder, should
be monitored closely as well as behavioral problems and valvular
heart diseases [5]. Other phenotypes include pulmonary hypopla-
sia, cardiovascular defects, craniofacial dysmorphism with trig-
onocephaly and forehead prominence, midfacial dysplasia with
anteverted nares, a long philtrum, gonadal dysgenesis with sex
reversal, hypospadias, cryptorchidism, and malformed external
genitalia, etc. Precise links between genotype and phenotype have
not yet been established because the phenotype varies extraordi-
narily widely. Some 9p deletion cases with major congenital
anomalies can be observed by prenatal examinations, as in this
case. Therefore, cytogenetic analysis is beneﬁcial for early diagnosis
and subsequent genetic counseling. In our case, after discussion,
the parents decided to undergomedical termination because of the
severe limb deformities in the fetus.
In conclusion, we carried out an analysis of chromosome 9, with
a breakpoint associated with omphalocele and symbrachydactyly.
Further genetic work on breakpoints in regions 13e22 might be
necessary to identify the genetic causes of these developmental
anomalies.Conﬂicts of interest
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